Douglas Parker

619 total citations
28 papers, 457 citations indexed

About

Douglas Parker is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Douglas Parker has authored 28 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Douglas Parker's work include Cutaneous Melanoma Detection and Management (6 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (4 papers). Douglas Parker is often cited by papers focused on Cutaneous Melanoma Detection and Management (6 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (4 papers). Douglas Parker collaborates with scholars based in United States and United Kingdom. Douglas Parker's co-authors include J.L. Turk, Keith A. Delman, Rik J. Scheper, Grant W. Carlson, Andrew J. Page, Douglas R. Murray, Benjamin K. Stoff, Cynthia Cohen, Ron Yaar and Andrea Hestley and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and Infection and Immunity.

In The Last Decade

Douglas Parker

28 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Parker United States 13 205 134 104 101 73 28 457
Alex Anstey United Kingdom 9 109 0.5× 80 0.6× 186 1.8× 298 3.0× 125 1.7× 22 584
Stefan Härtle Germany 10 78 0.4× 130 1.0× 78 0.8× 40 0.4× 70 1.0× 12 368
Andrew J. Portuguese United States 10 126 0.6× 234 1.7× 28 0.3× 54 0.5× 151 2.1× 36 542
M. Ara Spain 15 212 1.0× 86 0.6× 274 2.6× 265 2.6× 90 1.2× 53 631
Elsemieke I. Plasmeijer Netherlands 13 190 0.9× 71 0.5× 163 1.6× 284 2.8× 41 0.6× 30 435
Stephanie S. Cush United States 10 107 0.5× 295 2.2× 16 0.2× 170 1.7× 60 0.8× 11 518
Angela M. Wolbink Netherlands 13 62 0.3× 383 2.9× 18 0.2× 174 1.7× 206 2.8× 15 703
Bhupesh B. Desai United States 7 229 1.1× 569 4.2× 30 0.3× 81 0.8× 82 1.1× 11 735
Cristina Bordea United Kingdom 8 308 1.5× 48 0.4× 189 1.8× 346 3.4× 64 0.9× 11 502
Christy Kim United States 4 59 0.3× 384 2.9× 71 0.7× 85 0.8× 72 1.0× 5 620

Countries citing papers authored by Douglas Parker

Since Specialization
Citations

This map shows the geographic impact of Douglas Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Parker more than expected).

Fields of papers citing papers by Douglas Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Parker. The network helps show where Douglas Parker may publish in the future.

Co-authorship network of co-authors of Douglas Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Parker. A scholar is included among the top collaborators of Douglas Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Parker. Douglas Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maley, Alexander, et al.. (2015). Discordance of histopathologic parameters in cutaneous melanoma: Clinical implications. Journal of the American Academy of Dermatology. 74(1). 75–80. 45 indexed citations
2.
Oliver, Daniel, Kirtesh R. Patel, Jeffrey M. Switchenko, et al.. (2015). Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Melanoma Research. 26(1). 35–41. 18 indexed citations
3.
Oliver, Daniel, Kirtesh R. Patel, Douglas Parker, et al.. (2015). The emerging role of radiotherapy for desmoplastic melanoma and implications for future research. Melanoma Research. 25(2). 95–102. 4 indexed citations
4.
Maley, Alexander, Robert A. Swerlick, Douglas Parker, & Benjamin K. Stoff. (2015). Should dermatopathologists participate in diagnostic error disclosure to patients? An ethical analysis. Journal of the American Academy of Dermatology. 72(5). 901–904. 3 indexed citations
5.
Cendales, Linda C., Robert A. Bray, Howard M. Gebel, et al.. (2015). Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report. American Journal of Transplantation. 15(8). 2250–2255. 30 indexed citations
6.
Dhillon, Navneet K., Keith A. Delman, Derek Maetzold, et al.. (2012). Gene expression profile signature (DecisionDx-Melanoma) to predict visceral metastatic risk in patients with stage I and stage II cutaneous melanoma.. Journal of Clinical Oncology. 30(15_suppl). 8543–8543. 2 indexed citations
7.
Ghazi, Bahair H., Grant W. Carlson, Douglas R. Murray, et al.. (2010). Utility of Lymph Node Assessment for Atypical Spitzoid Melanocytic Neoplasms. Annals of Surgical Oncology. 17(9). 2471–2475. 29 indexed citations
8.
Stoff, Benjamin K., et al.. (2010). Dermatopathology of skin cancer in solid organ transplant recipients. Transplantation Reviews. 24(4). 172–189. 20 indexed citations
9.
Carlson, Grant W., Andrew J. Page, Cynthia Cohen, et al.. (2008). Regional Recurrence After Negative Sentinel Lymph Node Biopsy for Melanoma. Annals of Surgery. 248(3). 378–386. 95 indexed citations
10.
Richards, J.D., et al.. (2005). MINTREXTM Zn and MINTREXTM Cu organic trace minerals improve intestinal strength and immune response to coccidiosis infection and/or vaccination in broilers.. 257–259. 2 indexed citations
11.
Chiller, Katarina, Douglas Parker, & Carl V. Washington. (2004). Myofibrosarcoma Treated with Mohs Micrographic Surgery. Dermatologic Surgery. 30(12p2). 1565–1567. 6 indexed citations
12.
Baker, David, Douglas Parker, Don Healey, & J.L. Turk. (1987). Induction of sensitization and tolerance in contact sensitivity with haptenated epidermal cells in the guinea-pig.. PubMed. 62(4). 659–64. 2 indexed citations
13.
Baker, Daryll, Douglas Parker, & J.L. Turk. (1985). Effect of depletion of epidermal dendritic cells on the induction of contact sensitivity in the guinea-pig. British Journal of Dermatology. 113(3). 285–294. 18 indexed citations
14.
Turk, J.L., et al.. (1984). The effect of cyclophosphamide on immunological control mechanisms.. PubMed. 6(3). 205–11. 12 indexed citations
15.
Katayama, Ichiro, Douglas Parker, & J.L. Turk. (1982). In vivo macrophage suppression of delayed hypersensitivity in the guinea-pig.. PubMed. 47(4). 709–16. 7 indexed citations
16.
Parker, Douglas & J.L. Turk. (1982). Kinetics of the relation between suppressor and effector mechanisms in contact sensitivity in the guinea-pig.. PubMed. 47(1). 61–6. 12 indexed citations
17.
Dwyer, John M., Douglas Parker, & J.L. Turk. (1981). Suppression of delayed hypersensitivity to tuberculin by antigenic competition. A positive immunoregulatory mechanism sensitive to cyclophosphamide.. PubMed. 42(4). 549–59. 19 indexed citations
18.
Henderson, D C, Douglas Parker, & J.L. Turk. (1980). Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.. PubMed. 39(1). 1–9. 7 indexed citations
19.
Noble, B, Douglas Parker, Rik J. Scheper, & J.L. Turk. (1977). The relation between B-cell stimulation and delayed hypersensitivity. The effect of cyclophosphamide pretreatment on antibody production.. PubMed. 32(6). 885–91. 17 indexed citations
20.
Parker, Douglas, J.L. Turk, & Rik J. Scheper. (1976). Central and peripheral action of suppressor cells in contact sensitivity in the guinea-pig.. PubMed. 30(4). 593–7. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026